UA93405C2 - Фармацевтическая композиция для инъекционного введения, которая содержит соединение четырехвалентной платины - Google Patents

Фармацевтическая композиция для инъекционного введения, которая содержит соединение четырехвалентной платины

Info

Publication number
UA93405C2
UA93405C2 UAA200814647A UAA200814647A UA93405C2 UA 93405 C2 UA93405 C2 UA 93405C2 UA A200814647 A UAA200814647 A UA A200814647A UA A200814647 A UAA200814647 A UA A200814647A UA 93405 C2 UA93405 C2 UA 93405C2
Authority
UA
Ukraine
Prior art keywords
independently
carbon atoms
another
pharmaceutical composition
group
Prior art date
Application number
UAA200814647A
Other languages
English (en)
Ukrainian (uk)
Inventor
Алес Франк
Петр Сова
Original Assignee
Плива-Лахема A.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Плива-Лахема A.C. filed Critical Плива-Лахема A.C.
Publication of UA93405C2 publication Critical patent/UA93405C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Данное изобретение касается фармацевтической композиции для инъекционного, в частности целевого местного, введения, которая содержит стерильную суспензию комплекса платины общей формулы:(II),в фармацевтически приемлемой гидрофильной или гидрофобной жидкой фазе, причем 100 % частиц комплекса структурной формулы II имеют размер, меньше чем 250 мкм.
UAA200814647A 2006-06-20 2007-06-20 Фармацевтическая композиция для инъекционного введения, которая содержит соединение четырехвалентной платины UA93405C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20060401A CZ300590B6 (cs) 2006-06-20 2006-06-20 Farmaceutická kompozice pro injekcní podání

Publications (1)

Publication Number Publication Date
UA93405C2 true UA93405C2 (ru) 2011-02-10

Family

ID=38658280

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200814647A UA93405C2 (ru) 2006-06-20 2007-06-20 Фармацевтическая композиция для инъекционного введения, которая содержит соединение четырехвалентной платины

Country Status (14)

Country Link
US (1) US20090175947A1 (ru)
EP (1) EP2035020B1 (ru)
JP (1) JP2009541229A (ru)
KR (1) KR20090040299A (ru)
CN (1) CN101505765A (ru)
AT (1) ATE488243T1 (ru)
AU (1) AU2007262496A1 (ru)
CZ (1) CZ300590B6 (ru)
DE (1) DE602007010625D1 (ru)
IL (1) IL196098A0 (ru)
PL (1) PL2035020T3 (ru)
RU (1) RU2440113C2 (ru)
UA (1) UA93405C2 (ru)
WO (1) WO2007147373A2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
US10457700B2 (en) 2015-03-06 2019-10-29 University Of Georgia Research Foundation, Inc. Platinum prodrugs and methods of making and using thereof
HUE056897T2 (hu) 2015-12-09 2022-03-28 Univ Wien Med Monomaleimid-funkcionalizált platinavegyületek rákterápiához
CN116120376B (zh) * 2023-02-28 2025-09-09 中国科学技术大学 多不饱和脂肪酸与顺铂偶联形成的四价铂前药及制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62207283A (ja) * 1986-03-07 1987-09-11 Yoshinori Kitani 新規な白金錯体
ES2063119T3 (es) * 1988-02-02 1995-01-01 Johnson Matthey Inc Complejos de pt (iv).
US5549910A (en) * 1989-03-31 1996-08-27 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
FI905018A7 (fi) * 1989-10-17 1991-04-18 Bristol Myers Squibb Co Veteen ja liuottimeen liukenevat aksiaaliset hydroksi- ja mono- ja di-karboksyylihappojohdannaiset, joilla on korkea kasvainaktiivisuus
WO1996026949A1 (en) * 1995-02-28 1996-09-06 Debiopharm Sa Novel platinum (iv) complexes, process for producing the same, and carcinostatic agents containing the same
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
CZ288912B6 (cs) * 1998-05-27 2001-09-12 Lachema, A. S. Komplex platiny v oxidačním čísle IV, způsob přípravy tohoto komplexu, tento komplex jako léčivo a farmaceutická kompozice tento komplex obsahující
KR100317473B1 (ko) * 1999-05-11 2001-12-22 이계호 신규의 백금(ｉｖ)착제 및 그 제조방법
EP1253921A4 (en) * 2000-01-28 2004-10-13 Merck & Co Inc TREATMENT AND PROPHYLAXIS OF PROSTATE CANCER WITH COX-2 SELECTIVE INHIBITORS
CA2326004A1 (en) * 2000-11-02 2002-05-02 Richard E. Jones Methods for treating cellular proliferative disorders
WO2004047800A2 (en) * 2002-11-26 2004-06-10 Gilead Sciences, Inc. Method of drug loading in liposomes by gradient
CZ295584B6 (cs) * 2004-02-12 2005-08-17 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice
UA80872C2 (ru) * 2003-03-31 2007-11-12 Пліва-Лахема А.С. Фармацевтическая композиция, которая содержит как активное вещество платиновый комплекс, и способ ее изготовления
CZ296169B6 (cs) * 2004-09-08 2006-01-11 Pliva - Lachema A. S. Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CZ2004964A3 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
EP1811963A4 (en) * 2004-11-08 2010-01-06 Transave Inc METHOD FOR CREATING TREATMENT WITH INTRAPERITONEALLY APPLIED PLATINUM COMPOUND FORMULATIONS ON LIPID BASIS
US7601331B2 (en) * 2004-11-10 2009-10-13 National University Of Singapore NIR-sensitive nanoparticle
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Also Published As

Publication number Publication date
WO2007147373A2 (en) 2007-12-27
JP2009541229A (ja) 2009-11-26
WO2007147373B1 (en) 2008-05-15
EP2035020B1 (en) 2010-11-17
KR20090040299A (ko) 2009-04-23
CZ2006401A3 (cs) 2007-12-27
CN101505765A (zh) 2009-08-12
RU2009101493A (ru) 2010-07-27
RU2440113C2 (ru) 2012-01-20
US20090175947A1 (en) 2009-07-09
WO2007147373A3 (en) 2008-03-13
ATE488243T1 (de) 2010-12-15
AU2007262496A1 (en) 2007-12-27
DE602007010625D1 (de) 2010-12-30
CZ300590B6 (cs) 2009-06-24
EP2035020A2 (en) 2009-03-18
IL196098A0 (en) 2009-09-01
PL2035020T3 (pl) 2011-05-31

Similar Documents

Publication Publication Date Title
AU2014251087B2 (en) Formulations of oxabicycloheptanes and oxabicycloheptenes
MA34286B1 (fr) Compositions pharmaceutiques et procédés pour les fabriquer
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
JP6592097B2 (ja) 併用療法
MA33922B1 (fr) Dérivés hétéroaromatiques de phénylimidazole en tant qu'inhibiteurs de l'enzyme pde10a
PT2280706E (pt) Composições compreendendo derivados de benzeno que activam lipase de lipoproteína
TW200738658A (en) Novel compounds
MX2009004337A (es) Compuestos lipidos omega-3.
TW200626553A (en) Novel compounds
IL196098A0 (en) Pharmaceutical composition for injectional , particularly targeted local administration
AR062217A1 (es) Derivados de 4- trimetilamonio-3- aminobutirato y 4- trimetilfosfonio-3-aminobutirato como inhibidores de la cpt
BRPI0507657A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para tratar um distúrbio, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
MX2010003914A (es) Nuevas composiciones a base de taxoides.
MX2008008556A (es) Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
GEP20115240B (en) Indole derivatives, process for their preparation and pharmaceutical compositions containing them
DE602005025382D1 (de) Orale pharmazeutische zusammensetzung für den gezierwendung als medikament
UA93715C2 (ru) Фармацевтическая композиция для инъекционного введения ha ochobe соединения четырехвалентной платины и циклодекстрина
UA93404C2 (ru) Фармацевтическая композиция для орального введения суспензированного комплекса четырехвалентной платины
GEP20115192B (en) Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
BRPI0614099B8 (pt) uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto e o referido composto
TW200635925A (en) Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
DE60326731D1 (de) Arzneizubereitung und deren anwendung zur behandlu
TN2012000267A1 (fr) Nouveaux derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2022101807A (ru) Гетероциклическое соединение